Form D · Biotechnology

Codetta Bio Inc.

Morrisville, NC · CIK 0002025372

Offering snapshot reported Oct 30, 2024 · SEC filing

Reported sold
$12.3M
Offering amount: $26.4M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 21, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$6.14M$12.3MJun 5, 2024: $2,262,162.00Jun 5, 2024Oct 30, 2024: $12,280,996.00Oct 30, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,262,162 → $12,280,996

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 30, 2024Amendment$12,280,996$10,018,834vs Jun 5, 20244SEC filing
Jun 5, 2024Initial$2,262,162No comparison4SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-515143
Total offering amount includes the conversion of approximately $6,175,676 of principal and interest on outstanding convertible notes.

Source: Form D, filed Oct 30, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jacques Corriveau Director, Executive
William Hampton Henley Executive
John Ho Director
J. Michael Ramsey Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
140 Southcenter Ct. Suite 200
Morrisville, NC, 27560